CD274 and congenital T-cell immunodeficiency: Although it is widely assumed that PD-1/PD-L1 and other immune checkpoint Abs eliminate tumors by restoring the immune cytotoxic ability of T cells, treatment with the anti-PD-L1 Abs in T-cell deficiency tumor mice has been shown to inhibit tumor growth (36).